My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 128

    1.

    Genetic risk assessment and BRCA mutation testing.

    Eisinger F, Horsman DE.

    Ann Intern Med. 2006 Mar 7;144(5):376; author reply 376-7. No abstract available. PMID: 16520482 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations.

    [No authors listed]

    Ann Intern Med. 2005 Sep 6;143(5):I47. No abstract available. PMID: 16144889 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Genetic risk assessment and BRCA mutation testing.

    Ormond KE, Bellcross C, Weissman S.

    Ann Intern Med. 2006 Feb 21;144(4):303-4; discussion 304. No abstract available. PMID: 16490919 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2005 Sep 6;143(5):355-61. Review. Erratum in: Ann Intern Med. 2005 Oct 4;143(7):547. PMID: 16144894 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.

    Wolff TA, Wilson JE.

    Am Fam Physician. 2006 Nov 15;74(10):1759-60. Review. No abstract available. PMID: 17137007 [PubMed - indexed for MEDLINE]Related articles

    6.

    Management of the BRCA mutation carrier or high-risk patient.

    Bordeleau LJ, Lipa JE, Neligan PC.

    Clin Plast Surg. 2007 Jan;34(1):15-27; abstract v. Review.PMID: 17307068 [PubMed - indexed for MEDLINE]Related articles

    7.

    Choices--and uncertainties--for women with BRCA mutations.

    Couzin J.

    Science. 2003 Oct 24;302(5645):592. No abstract available. PMID: 14576419 [PubMed - indexed for MEDLINE]Related articles

    8.

    Breast cancer risk assessment and genetic testing: complexities, conundrums, and community.

    Peshkin BN.

    Breast Dis. 2006-2007;27:1-3. No abstract available. PMID: 17917137 [PubMed - indexed for MEDLINE]Related articles

    9.

    Genetic risk in context: calculating the penetrance of BRCA1 and BRCA2 mutations.

    Burke W, Austin MA.

    J Natl Cancer Inst. 2002 Aug 21;94(16):1185-7. No abstract available. PMID: 12189215 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Ductal carcinoma in situ in BRCA mutation carriers.

    Hwang ES, McLennan JL, Moore DH, Crawford BB, Esserman LJ, Ziegler JL.

    J Clin Oncol. 2007 Feb 20;25(6):642-7. Epub 2007 Jan 8.PMID: 17210933 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.

    Bonadona V, Sinilnikova OM, Lenoir GM, Lasset C.

    J Natl Cancer Inst. 2002 Oct 16;94(20):1582-3; author reply 1583-4. No abstract available. PMID: 12381714 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Childhood cancer in families with and without BRCA1 or BRCA2 mutations ascertained at a high-risk breast cancer clinic.

    Brooks GA, Stopfer JE, Erlichman J, Davidson R, Nathanson KL, Domchek SM.

    Cancer Biol Ther. 2006 Sep;5(9):1098-102. Epub 2006 Sep 11.PMID: 16931905 [PubMed - indexed for MEDLINE]Related articles

    13.

    Modeling genetic risk of breast cancer.

    Kauff ND, Offit K.

    JAMA. 2007 Jun 20;297(23):2637-9. No abstract available. PMID: 17579233 [PubMed - indexed for MEDLINE]Related articles

    14.

    Limited family structure and BRCA gene mutation status in single cases of breast cancer.

    Weitzel JN, Lagos VI, Cullinane CA, Gambol PJ, Culver JO, Blazer KR, Palomares MR, Lowstuter KJ, MacDonald DJ.

    JAMA. 2007 Jun 20;297(23):2587-95.PMID: 17579227 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Limited family structure and breast cancer risk.

    Iversen ES Jr, Katki HA, Chen S, Berry DA, Parmigiani G.

    JAMA. 2007 Nov 7;298(17):2007; author reply 2007-8. No abstract available. PMID: 17986693 [PubMed - indexed for MEDLINE]Related articles

    16.

    Clinical practice. Management of an inherited predisposition to breast cancer.

    Robson M, Offit K.

    N Engl J Med. 2007 Jul 12;357(2):154-62. Review. No abstract available. PMID: 17625127 [PubMed - indexed for MEDLINE]Related articles

    17.

    The need for public education: "Surveillance and risk reduction strategies" for women at risk for carrying BRCA gene mutations.

    Nisker JA.

    J Obstet Gynaecol Can. 2007 Jun;29(6):510-1. No abstract available. PMID: 17568484 [PubMed - indexed for MEDLINE]Related articles

    18.

    Surgical treatment planning in newly diagnosed breast cancer patients at high risk for BRCA-1 or BRCA-2 mutation.

    Chung MA, Cady B.

    Breast J. 2004 Nov-Dec;10(6):473-4. No abstract available. PMID: 15569200 [PubMed - indexed for MEDLINE]Related articles

    19.

    Numerous high-risk epithelial lesions in familial breast cancer.

    Hoogerbrugge N, Bult P, Bonenkamp JJ, Ligtenberg MJ, Kiemeney LA, de Hullu JA, Boetes C, Niermeijer MF, Brunner HG.

    Eur J Cancer. 2006 Oct;42(15):2492-8.PMID: 16908132 [PubMed - indexed for MEDLINE]Related articles

    20.

    Double heterozygotes for non-Caucasian families with mutations in BRCA-1 and BRCA-2 genes.

    Choi DH, Lee MH, Haffty BG.

    Breast J. 2006 May-Jun;12(3):216-20.PMID: 16684319 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity